Corrigendum to "Pharmacological Characterization of Zasocitinib (TAK-279): An Oral, Highly Selective and Potent Allosteric TYK2 Inhibitor" Journal of Investigative Dermatology, Volume 146, Issue 1, January 2026, Pages 214-222.e7.

Authors

Shailly Mehrotra, Yasuyo Sano, Petro Halkowycz, Elizabeth Wilson, Chandra Durairaj, Kok-Fai Kong, Guliang Xia, Faith Dunbar, Taylor Spector, Graham A Heap, Christopher G Bunick, Iain B McInnes

Published in

The Journal of investigative dermatology. Sep 08, 2026. Epub Sep 08, 2026.

PMID:
42714361
Bibliographic data and abstract were imported from PubMed on 09 Sep 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.